Products

EFAI RTSuite CT HN-Segmentation System
Ever Fortune.AI Co., Ltd.
Oncology AI
EFAI RTSuite CT HN-Segmentation System is an FDA-cleared AI tool that automatically delineates head-and-neck organs-at-risk (OARs) on CT images to streamline radiation therapy treatment planning workflows for trained oncology professionals.
EFAI ChestSuite XR Pleural Effusion Assessment System
Ever Fortune.AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pleural Effusion Assessment System is an AI-powered radiological computer-assisted triage and notification software that analyzes PA chest X-rays to identify and flag suspected pleural effusion, aiding in workflow prioritization.
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Ever Fortune.AI Co.
Radiology & Imaging AI
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is an FDA-cleared AI software that quantifies bone age from left-hand X-rays for pediatric patients (2-16 years old), assisting radiologists in diagnosis and workflow efficiency.

See all 9 products →

About Ever Fortune. AI

Ever Fortune.AI is a healthcare AI company specializing in AI-driven diagnostic solutions and cloud-based biomedical platforms. The company leverages advanced artificial intelligence and big data analysis to enhance medical workflows, optimize disease monitoring, and advance precision medicine. Their offerings are designed to assist hospitals and healthcare providers in achieving more efficient and precise medical analysis and decision-making.

Their comprehensive suite of AI-powered products integrates genetic, physiological, and imaging data to create predictive models for various medical specialties. Key applications include systems for radiographic bone age interpretation, height prediction, ultrasound-based tumor classification, liver cancer metastasis risk management, liver fibrosis evaluation, and cardiac arrhythmia detection. They also focus on AI adaptive radiotherapy, ECG analysis, chest X-ray assessment, RT organ auto-contouring, brain hemorrhage detection, aortic dissection, pediatric growth assessment, bone scintigraphy, and myocardial perfusion.

Ever Fortune.AI is committed to driving the transformation of healthcare delivery by providing customized AI technology solutions that improve clinical outcomes and operational efficiency. The company has secured numerous medical device certifications from regulatory bodies, including Taiwan’s TFDA and the U.S. FDA, demonstrating their commitment to quality and safety in their innovative digital healthcare solutions.

Focus Areas

Oncology Neurology Cardiology Digital Medicine Precision Medicine Medical Big Data Cloud-based Biomedical Platforms AI-assisted Diagnostics Disease Prediction Radiographic Bone Age Interpretation Height Prediction Ultrasound-based Tumor Classification Liver Cancer Metastasis Risk Management Liver Fibrosis Evaluation Cardiac Arrhythmia Detection ECG Analysis Chest X-ray Analysis Radiotherapy Planning Brain Hemorrhage Detection Acute Aortic Syndrome Assessment Pediatric Bone Age Analysis Bone Scintigraphy PACS

Business Intelligence

PartnershipsVarian, China Medical University, Kaohsiung Veterans General Hospital, Tungs' Taichung MetroHarbor Hospital, University Medical Shing Mark Hospital (Vietnam), GE, Siemens
TechnologyAI-driven diagnostic solutions, deep learning algorithms, medical big data analysis, cloud-based biomedical platforms, closed-loop artificial intelligence algorithm modules, genetic algorithms, simulated annealing algorithms, AI-driven workflow optimization, real-time data analysis, DICOM-compliant systems
FDA Clearances13 cleared products (estimated)

What Physicians Need to Know

Oncology Solutions
Ever Fortune.AI offers AI-driven solutions for comprehensive cancer care, including an AI Adaptive Radiotherapy Platform for personalized and precision treatment, which rapidly segments CT/MRI images and recommends radiation doses. Their 'EFAI RT Suite CT HCAP-Segmentation System' automatically delineates critical organs-at-risk on CT images for radiotherapy planning. They also provide Computer-Assisted Detection Platforms for Bone Scintigraphy to aid in detecting potential bone metastases and tools for liver cancer metastasis risk management and ultrasound-based tumor classification.
Neurology Diagnostics
In neurology, Ever Fortune.AI specializes in AI-assisted diagnostics for critical conditions. Their 'NeuroSuite CT ICH Assessment System' accurately detects and identifies five types of intracerebral hemorrhage (ICH) in non-contrast CT scans, aiding in rapid diagnosis.
Cardiology Assessments
The company provides a suite of cardiology solutions, including 'ECG Analysis Software' for automatic rhythm interpretation and quick identification of heart anomalies. Their 'STEMI Detection Software' assists in rapidly detecting acute myocardial infarction. The 'ChestSuite XR Assessment System' identifies 15 abnormal findings in chest X-ray images, and the 'EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM' uses deep learning to flag suspected cases of aortic dissection or intramural hematoma for workflow triage. Additionally, they offer 'Cardiosuite SPECT Myocardial Perfusion Agile Workflows' for nuclear radiologists.
Digital & Precision Medicine
Ever Fortune.AI is a pioneer in digital and precision medicine, leveraging medical big data and cloud-based biomedical platforms. Their 'Pediatric Growth Assessment System' integrates multidimensional data (bone age, height, weight, BMI) for time-trend reports, with FDA- and TFDA-approved bone age interpretation software. They also offer a 'Gene Meta Platform' for genetic risk assessment and an 'Intelligent Health Check Scheduling System' to optimize patient flow.
AI-Assisted Diagnostics & Platforms
At its core, Ever Fortune.AI focuses on AI-assisted diagnostics and cloud-based biomedical platforms. Their solutions utilize advanced AI and deep learning algorithms to analyze vast datasets from patient records, medical imaging, and physiological data, enabling early disease identification and prediction. The platforms are designed to be agile, flexible, and scalable, supporting cloud, on-premises, or hybrid deployments, and are ready for major cloud providers like AWS, Azure, or GCP. They also offer PACS (Picture Archiving and Communication System) for managing digital images and communications.
Physician Tip

For physicians, Ever Fortune.AI's solutions offer a significant advantage by enhancing diagnostic accuracy and efficiency, allowing for faster intervention and improved patient outcomes. The AI acts as a 'pre-read assistance' for medical images, reducing interpretation time and enabling medical teams to focus on more complex clinical decisions and patient communication. Their extensive portfolio of FDA and TFDA cleared devices provides a strong assurance of reliability and safety. The ability to integrate genetic, physiological, and imaging data offers a more holistic view for personalized treatment plans. Physicians should consider how these AI tools can streamline workflows, prioritize urgent cases, and provide objective data to support clinical judgment, ultimately leading to better quality care.

Ever Fortune.AI's platforms are designed for high compatibility and seamless integration within existing hospital infrastructures. Their radiotherapy planning systems are highly compatible with any brand of Treatment Planning System (TPS). The bone age interpretation software can be customized to integrate with existing PACS systems. Their acute aortic syndrome assessment system alerts PACS/RIS workstations for worklist prioritization. The cloud-based biomedical platforms are built with flexibility in mind, supporting cloud, on-premises, or hybrid systems and are compatible with major cloud providers (AWS, Azure, GCP), ensuring adherence to local regulations and security protocols. This modular and adaptable design suggests a strong focus on interoperability with various medical imaging modalities, hospital information systems, and electronic health records.

Products by Ever Fortune. AI

9 products in the directory

EFAI RTSuite CT HN-Segmentation System
Ever Fortune.AI Co., Ltd.
Oncology AI
EFAI RTSuite CT HN-Segmentation System is an FDA-cleared AI tool that automatically delineates head-and-neck organs-at-risk (OARs) on CT images to streamline radiation therapy treatment planning workflows for trained oncology professionals.
EFAI ChestSuite XR Pleural Effusion Assessment System
Ever Fortune.AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pleural Effusion Assessment System is an AI-powered radiological computer-assisted triage and notification software that analyzes PA chest X-rays to identify and flag suspected pleural effusion, aiding in workflow prioritization.
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Ever Fortune.AI Co.
Radiology & Imaging AI
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is an FDA-cleared AI software that quantifies bone age from left-hand X-rays for pediatric patients (2-16 years old), assisting radiologists in diagnosis and workflow efficiency.
EFAI RTSUITE CT HCAP-Segmentation System
Ever Fortune.AI Co.
Oncology AI
The EFAI RTSUITE CT HCAP-Segmentation System is an FDA-cleared AI-powered software by Ever Fortune.AI Co. that automates the outlining of critical organs at risk on CT scans for radiation therapy treatment planning, enhancing workflow efficiency and accuracy for oncology professionals.
EFAI NeuroSuite CT ICH Assessment System
Ever Fortune.AI Co.
Neurology AI
The EFAI NeuroSuite CT ICH Assessment System is an AI-powered radiological computer-assisted triage and notification software that uses deep learning to automatically analyze non-contrast head CTs for acute intracranial hemorrhage, alerting workstations for prioritized review.
EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)
Ever Fortune.AI
Radiology & Imaging AI
AI-powered computer-aided triage and notification software for assessing malpositioned endotracheal tubes on chest X-rays, designed to enhance patient safety and improve clinical outcomes through rapid alerts.
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM
Ever Fortune.AI
Cardiology AI
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM is an AI-powered radiological computer-assisted triage and notification software that rapidly detects features suggestive of acute aortic dissection or intramural hematoma from CTA images, alerting PACS/RIS workstations for earlier review.
EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)
Ever Fortune.AI
Clinical Decision Support & Reference
The EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) is an FDA-cleared AI software that automatically analyzes non-contrast head CTs to detect and prioritize cases with suspected midline shift, streamlining neurological emergency workflows.
EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System
Ever Fortune. AI Co.
Cardiology AI
The EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System is an AI-powered software for hospitals and clinics, designed to automatically measure the cardiothoracic ratio from chest X-ray images, enhancing diagnostic efficiency in cardiology.

Reviews & Opinions

No web reviews on file yet for Ever Fortune. AI. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Ever Fortune. AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ever Fortune. AI →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Ever Fortune.AI offers AI-driven solutions designed to integrate seamlessly into existing clinical workflows, particularly with PACS and EMR systems, by supporting DICOM standards and providing outputs like visual overlays or prioritization flags. Their product portfolio spans Oncology (e.g., radiotherapy planning, bone scintigraphy, liver cancer risk management), Neurology (e.g., brain hemorrhage detection), Cardiology (e.g., ECG analysis, acute aortic syndrome assessment, chest X-ray analysis), and Pediatrics (e.g., bone age assessment, height prediction).
Ever Fortune.AI's AI-assisted diagnostic tools are backed by numerous medical device certifications, including 13 U.S. FDA clearances and 16 Taiwan TFDA approvals, demonstrating their adherence to regulatory standards. These certifications cover a range of applications such as ECG, chest X-rays, RT organ auto-contouring, brain hemorrhage detection, and acute aortic syndrome assessment, indicating clinical validation for their utility in enhancing diagnostic precision and workflow efficiency.
Ever Fortune.AI's PACS Picture Archiving and Communication System is designed to manage digital images and communications in medicine, complying with DICOM standards for displaying, processing, storing, and transferring medical data. Their systems are built for secure, compliant, and enterprise-ready architecture, with AI outputs appearing as assistive insights within the PACS, ensuring radiologists remain in full control and data integrity is maintained. While specific details on HIPAA/GDPR are not provided, their numerous medical device approvals suggest a commitment to regulatory compliance in healthcare.
The implementation process for Ever Fortune.AI's solutions is structured to integrate smoothly with existing clinical systems, minimizing operational disruption through workflow assessment and secure system integration with PACS, RIS, and hospital infrastructure. They offer ongoing support, including monitoring, optimization, and clinical feedback loops, to ensure continuous performance and adaptation. Their bone age interpretation software, for instance, can be customized to integrate with existing PACS systems.
Ever Fortune.AI specializes in providing AI-driven diagnostic solutions and cloud-based biomedical platforms to hospitals and healthcare providers. While specific pricing models are not publicly detailed, their offerings are designed to enhance clinical workflows and patient outcomes, suggesting a value-based or subscription-based model common for enterprise AI software. Healthcare institutions interested in their solutions would need to contact Ever Fortune.AI directly for detailed pricing and tailored proposals.
Ever Fortune.AI has established strategic partnerships with major healthcare institutions, such as China Medical University and Varian, to develop advanced platforms like their AI Adaptive Radiotherapy Platform. They are also expanding internationally through collaborations with leading medical platforms in Europe, the U.S., and ASEAN markets, aiming for exponential growth. Their vision is to be a pioneer in digital healthcare, leveraging AI and big data to revolutionize the industry and bring solutions to experts anytime, anywhere, including developing generative AI healthcare robots.
Founded in 2018, Ever Fortune.AI is a public company that has demonstrated robust operational growth, with significant revenue increases in recent years. They have secured numerous patents and medical device approvals globally, showcasing a strong commitment to innovation and regulatory compliance. While they have reported net losses in some periods, analysts estimate the company turned profitable in 2024, indicating a positive trajectory for long-term stability and continued product development.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.